This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Srivenugopal, K. S. Articles by Ali-Osman, F. Search for Related Content PubMed PubMed Citation Articles by Srivenugopal, K. S. Articles by Ali-Osman, F.

Protein Phosphorylation Is a Regulatory Mechanism for O⁶-Alkylguanine-DNA Alkyltransferase in Human Brain Tumor Cells¹

Section of Molecular Therapeutics, Department of Neurosurgery, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030 [K. S. S., S. R. S. M., J. S., F. A.-O.], and the Sealy Center for Molecular Science, The University of Texas Medical Branch, Galveston, Texas 77555 [T. K. H.]

The biochemical regulation of human O⁶-alkylguanine-DNA alkyltransferase (AGT), which determines the susceptibility of normal tissues to methylating carcinogens and resistance of tumor cells to many alkylating agents, is poorly understood. We investigated the regulation of AGT by protein phosphorylation in a human medulloblastoma cell line. Incubation of cell extracts with [-³²P]ATP resulted in Mg²⁺-dependent phosphorylation of the endogenous AGT. Immunoprecipitation after exposure of the cells to ³²P-labeled inorganic phosphate showed that AGT exists as a phosphoprotein under physiological conditions. Western analysis and chemical stability studies showed the AGT protein to be phosphorylated at tyrosine, threonine, and serine residues. Purified protein kinase A (PKA), casein kinase II (CK II), and protein kinase C (PKC) phosphorylated the recombinant AGT protein with a stoichiometry of 0.15, 0.28, and 0.44 (mol phosphate incorporated/mol protein), respectively. Residual phosphorylation of the endogenous AGT by the PKs present in cell homogenates and phosphorylation of the recombinant AGT by purified serine/threonine kinases, PKA, PKC, and CK II reduced AGT activity by 30–65%. Conversely, dephosphorylation of cell extracts by alkaline phosphatases stimulated AGT activity. We also identified consensus phosphorylation motifs for many cellular kinases, including PKA and CK II in the AGT protein. These data provide the first and conclusive evidence of AGT phosphorylation and suggest that reversible phosphorylation may control the activity of this therapeutically important DNA repair protein in human normal and cancer cells.

This article has been cited by other articles:

				S. K. Niture, C. S. Velu, Q. R. Smith, G.J. Bhat, and K. S. Srivenugopal Increased expression of the MGMT repair protein mediated by cysteine prodrugs and chemopreventative natural products in human lymphocytes and tumor cell lines Carcinogenesis, February 1, 2007; 28(2): 378 - 389. [Abstract] [Full Text] [PDF]

				O. Humbert, I. Achour, D. Lautier, G. Laurent, and B. Salles hMSH2 expression is driven by AP1-dependent regulation through phorbol-ester exposure Nucleic Acids Res., October 1, 2003; 31(19): 5627 - 5634. [Abstract] [Full Text] [PDF]

				G. P. Margison, A. C. Povey, B. Kaina, and M. F. Santibanez Koref Variability and regulation of O6-alkylguanine-DNA alkyltransferase Carcinogenesis, April 1, 2003; 24(4): 625 - 635. [Abstract] [Full Text] [PDF]

				O. Humbert, T. Hermine, H. Hernandez, T. Bouget, J. Selves, G. Laurent, B. Salles, and D. Lautier Implication of Protein Kinase C in the Regulation of DNA Mismatch Repair Protein Expression and Function J. Biol. Chem., May 10, 2002; 277(20): 18061 - 18068. [Abstract] [Full Text] [PDF]

				S. L. Gerson Clinical Relevance of MGMT in the Treatment of Cancer J. Clin. Oncol., May 1, 2002; 20(9): 2388 - 2399. [Abstract] [Full Text] [PDF]

				M. Christmann, M. T. Tomicic, and B. Kaina Phosphorylation of mismatch repair proteins MSH2 and MSH6 affecting MutS{alpha} mismatch-binding activity Nucleic Acids Res., May 1, 2002; 30(9): 1959 - 1966. [Abstract] [Full Text] [PDF]

				M. Xu-Welliver and A. E. Pegg Degradation of the alkylated form of the DNA repair protein, O6-alkylguanine-DNA alkyltransferase Carcinogenesis, May 1, 2002; 23(5): 823 - 830. [Abstract] [Full Text] [PDF]

				M. Diaz, M. I Bahamonde, H. Lock, F. J Munoz, S. P Hardy, F. Posas, and M. A Valverde Okadaic acid-sensitive activation of Maxi Cl- channels by triphenylethylene antioestrogens in C1300 mouse neuroblastoma cells J. Physiol., October 1, 2001; 536(1): 79 - 88. [Abstract] [Full Text] [PDF]

				L. Liu, T. P. Spiro, X. Qin, S. Majka, J. Haaga, J. Schupp, J. K. V. Willson, and S. L. Gerson Differential Degradation Rates of Inactivated Alkyltransferase in Blood Mononuclear Cells and Tumors of Patients after Treatment with O6-Benzylguanine Clin. Cancer Res., August 1, 2001; 7(8): 2318 - 2324. [Abstract] [Full Text] [PDF]

				K. S. Srivenugopal, J. Shou, S. R. S. Mullapudi, F. F. Lang Jr., J. S. Rao, and F. Ali-Osman Enforced Expression of Wild-Type p53 Curtails the Transcription of the O6-Methylguanine-DNA Methyltransferase Gene in Human Tumor Cells and Enhances Their Sensitivity to Alkylating Agents Clin. Cancer Res., May 1, 2001; 7(5): 1398 - 1409. [Abstract] [Full Text]